Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of Oral MRX-1024 in Combination With Standard Fractionation Radiation Therapy and High-Dose Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck Following Surgical Resection
Conditions
Interventions
Oral MRX-1024
Standard Fractionation Radiation Therapy
+1 more
Start Date
January 1, 2007
Completion Date
July 1, 2007
Last Updated
November 14, 2012
NCT04929028
NCT07042295
NCT06980038
NCT05039801
NCT06806852
NCT07403136
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions